Actuate Therapeutics Inc (ACTU) vs Bionano Genomics, Inc. (BNGO)
A side-by-side comparison of Actuate Therapeutics Inc and Bionano Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACTU
Actuate Therapeutics Inc
$0.82HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
BNGO
Bionano Genomics, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 11:33 AM EDT
Total return — ACTU vs BNGO
growth of $100 · dividends reinvested · last 2yACTU -89.8% (-68.1%/yr)BNGO -94.4% (-76.2%/yr)ACTU compounded faster over this window
ACTU BNGO
ACTU vs BNGO: by the numbers
- •ACTU is the larger company ($20M vs $17M market cap).
- •Both run net losses; ACTU's is the smaller (0.00% vs -106.58% net margin).
Metrics side by side
Valuation
| Metric | ACTU | BNGO |
|---|---|---|
| P/S ratio | N/A | 0.56 |
| P/B ratio | 19.95 | 0.53 |
Profitability
| Metric | ACTU | BNGO |
|---|---|---|
| Gross margin | 0.00% | 21.95% |
| Operating margin | 0.00% | -116.95% |
| Net margin | 0.00% | -106.58% |
| ROE | -2067.81% | -101.76% |
| ROIC | -1489.99% | -85.72% |
Growth (annualized)
| Metric | ACTU | BNGO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 17.97% |
| Total return CAGR (5Y) | N/A | -78.37% |
Go deeper
Dig into the metrics
Actuate Therapeutics ROEBionano Genomics ROEActuate Therapeutics operating marginBionano Genomics operating marginActuate Therapeutics revenue growthBionano Genomics revenue growthActuate Therapeutics free cash flowBionano Genomics free cash flow
Actuate Therapeutics & Bionano Genomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.